| abstract |
Compounds of formula I (I) are provided. In which T, A, Q, Z, G, R 4 , R 5a , R 5b and n have the meanings given in the text of the specification and the compounds can be used, for example , Syk kinase, and anti-inflammatory activity (by inhibition of one or more members of the Src family of tyrosine kinases), especially inflammatory diseases, including inflammatory diseases of the lung, eye and intestine It is used for therapy including drug combination in the treatment of |